CN103417923A - Drug for curing digestive ulcer - Google Patents
Drug for curing digestive ulcer Download PDFInfo
- Publication number
- CN103417923A CN103417923A CN2012101542624A CN201210154262A CN103417923A CN 103417923 A CN103417923 A CN 103417923A CN 2012101542624 A CN2012101542624 A CN 2012101542624A CN 201210154262 A CN201210154262 A CN 201210154262A CN 103417923 A CN103417923 A CN 103417923A
- Authority
- CN
- China
- Prior art keywords
- radix
- drug
- rhizoma
- ulcer
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 229940079593 drug Drugs 0.000 title abstract description 9
- 208000025865 Ulcer Diseases 0.000 title abstract description 8
- 231100000397 ulcer Toxicity 0.000 title abstract description 8
- 230000001079 digestive effect Effects 0.000 title abstract 4
- 239000000463 material Substances 0.000 claims abstract description 6
- 241000756943 Codonopsis Species 0.000 claims abstract description 5
- 241000218176 Corydalis Species 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 3
- 208000008469 Peptic Ulcer Diseases 0.000 claims description 9
- 208000011906 peptic ulcer disease Diseases 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- 210000003038 endothelium Anatomy 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 29
- 230000036407 pain Effects 0.000 abstract description 29
- 210000004369 blood Anatomy 0.000 abstract description 21
- 210000002784 stomach Anatomy 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 20
- 210000000952 spleen Anatomy 0.000 abstract description 14
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 238000010792 warming Methods 0.000 abstract description 6
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 abstract 1
- 206010020601 Hyperchlorhydria Diseases 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 244000272264 Saussurea lappa Species 0.000 abstract 1
- 235000006784 Saussurea lappa Nutrition 0.000 abstract 1
- 241000238371 Sepiidae Species 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 210000004317 gizzard Anatomy 0.000 abstract 1
- 229940010454 licorice Drugs 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 18
- 235000019634 flavors Nutrition 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000007107 Stomach Ulcer Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 230000000767 anti-ulcer Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 208000000718 duodenal ulcer Diseases 0.000 description 4
- 201000005917 gastric ulcer Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010016326 Feeling cold Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 229940069428 antacid Drugs 0.000 description 3
- 239000003159 antacid agent Substances 0.000 description 3
- 230000001458 anti-acid effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- -1 Corydaline Natural products 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010057071 Rectal tenesmus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- VRSRXLJTYQVOHC-YEJXKQKISA-N corydaline Chemical compound C=1([C@H]2[C@H]3C)C=C(OC)C(OC)=CC=1CCN2CC1=C3C=CC(OC)=C1OC VRSRXLJTYQVOHC-YEJXKQKISA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 208000012271 tenesmus Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 210000004916 vomit Anatomy 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GDVRUDXLQBVIKP-HQHREHCSSA-N 1-O-galloyl-beta-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-HQHREHCSSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- VRSRXLJTYQVOHC-UHFFFAOYSA-N Corydaline Natural products CC1C2C=3C=C(OC)C(OC)=CC=3CCN2CC2=C1C=CC(OC)=C2OC VRSRXLJTYQVOHC-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010062890 Gastrolithiasis Diseases 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930190125 Sanguisorbin Natural products 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000001989 choleretic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- KKOXKGNSUHTUBV-UHFFFAOYSA-N racemic zingiberene Natural products CC(C)=CCCC(C)C1CC=C(C)C=C1 KKOXKGNSUHTUBV-UHFFFAOYSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229910001467 sodium calcium phosphate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- KKOXKGNSUHTUBV-LSDHHAIUSA-N zingiberene Chemical compound CC(C)=CCC[C@H](C)[C@H]1CC=C(C)C=C1 KKOXKGNSUHTUBV-LSDHHAIUSA-N 0.000 description 1
- 229930001895 zingiberene Natural products 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A drug for curing digestive ulcer belongs to the technology field of traditional Chinese medicine preparation. The drug is mainly composed of 18 kinds of raw materials such as radix codonopsis, bletilla striata, cuttlefish bone, corydalis tuber, chicken's gizzard membrane, combined spicebush, costus root, pseudo-ginseng, garden burnet root, licorice, etc. The drug for curing digestive ulcer has the functions of tonifying spleen, nourishing stomach, clearing away heat and toxic materials, regulating Qi to alleviate pains, warming spleen and stomach for dispelling cold, relieving hyperacidity, astringing sores, dissipating blood stasis, breaking stagnation of Qi, and resisting ulcer. The drug has a good curative effect on digestive ulcer after the drug being applied to clinical application, and has the advantages of user-friendliness and no side or toxic effect.
Description
Technical field
The invention belongs to the Chinese medicine preparation technical field.
Background technology
Peptic ulcer is a kind of mucosa, muscular layer of mucosa and submucosal chronic festering, and is generally gastric ulcer and duodenal ulcer.The patient has chronic periodicity, rhythmicity upper abdominal pain, is dull pain, distending pain, causalgia or severe pain etc.Gastric ulcer is feed → pain → alleviation; Duodenal ulcer is pain → feed → alleviation.Gastric ulcer is generally that the morning is light, and afternoon is heavy; It is characteristics that duodenal ulcer be take midnight pain.Can be with nauseating, pantothenic acid, belch etc.To the treatment of gastric ulcer, duodenal ulcer, generally adopt integrative medicine therapy.But western medical treatment is except the price height, and some Western medicine also has serious side effect.The general onset of Chinese traditional treatment is slower, and the course for the treatment of is longer.
Summary of the invention
The objective of the invention is to overcome existing technical deficiency, a kind of medicine of new treatment peptic ulcer is provided.The present invention has that strengthening the spleen and nourishing the stomach, clearing stomach expel the heat-evil, warming middle-JIAO to dispel cold, blood circulation promoting and blood stasis dispelling, antacid sore, regulating QI to relieve pain, antiulcer function, to peptic ulcer, can reach determined curative effect, has no side effect, and takes easy purpose.
The technical solution adopted for the present invention to solve the technical problems is:
The present invention consists of Radix Codonopsis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Fructus Crataegi, Fructus Amomi, Os Sepiae, Pericarpium Citri Reticulatae, Rhizoma Corydalis, Flos Lonicerae, Endothelium Corneum Gigeriae Galli, Rhizoma Cyperi, the Radix Linderae, Radix Aucklandiae (Radix Vladimiriae), Radix Et Rhizoma Rhei, Rhizoma Zingiberis Recens, Radix Angelicae Sinensis, Radix Notoginseng, charred Radix Sanguisorbae, Radix Glycyrrhizae 18 flavor material medicines.
Radix Codonopsis in the present invention, nature and flavor are sweet, flat.Sugary and Saponin.Invigorating middle warmer, QI invigorating, promote the production of body fluid.Cure mainly weakness of the spleen and stomach, fatigue and asthenia, cough due to deficiency of the lung, thirsty, few food.
The Pseudobulbus Bletillae (Rhizoma Bletillae) in the present invention, nature and flavor are bitter, flat.Containing volatile oil, phlegmatic temperament, starch etc.Tonifying the lung granulation promoting, arresting bleeding and healing up ulcer.Cure mainly deficiency of the lung haematemesis, epistaxis, lung abscess, consumptive lung disease, carbuncle.
Fructus Crataegi in the present invention, nature and flavor are sour, sweet, tepor.Containing citric acid, malic acid, vitamin E, carbohydrate, Crataegolic acid, lipolytic enzyme, saccharide, flavonoid, protein etc.Long-pending, dissipating blood stasis blood, broken stagnant gas help digestion.Cure mainly inner product and do not disappear, gastral cavity is vexed just to be let out, phlegm retention, mass in the abdomen, feeling of fullness, hernia, prolonged lochia, dysmenorrhea, children's's breast food are stagnated.
Fructus Amomi in the present invention, nature and flavor are flat, warm.Containing volatile oil, be mainly Borneolum Syntheticum, gum camphor, Borneolum Syntheticum acetic acid fat, linalool, orange blossom three enols etc.Circulation of qi promoting, adjust in, stomach function regulating, be amusing.Cure mainly swollen, the anorexia dyspepsia of stomachache painful abdominal mass, choke every vomiting, diarrhea due to cold pathogen cold-dysentery, pregnant fetal movement.
Os Sepiae in the present invention, have another name called Endoconcha Sepiae.Nature and flavor are salty, tepor.Containing calcium carbonate, sodium chloride and calcium phosphate, organic matter, magnesium salt etc.The antacid sore.Cure mainly the diseases such as metrostaxis, wound hemorrhage, seminal emission, women's leucorrhea with red and white discharge, gastralgia, acid regurgitation, skin infection, ulcer disunion of a specified duration.
Pericarpium Citri Reticulatae in the present invention, the nature and flavor acrid, bitter, warm.Enter spleen, lung, liver, stomach warp.Containing volatile oil, be mainly limonene, Chinese holly as aldehyde, separately containing hesperidin, carotene, cryptoxanthine, vitamin C, vitamin B
1With pectin etc.In regulating the flow of vital energy, adjusting, dampness, reduce phlegm.Cure mainly distension and fullness of the chest and abdomen, anorexia, vomit dirty contrary, cough with copious phlegm.
Rhizoma Corydalis in the present invention, acrid, bitter, warm.Enter liver, stomach warp.Containing multiple alkaloids such as Corydaline, second elements, and containing the volatilization wet goods.Promoting blood circulation to remove blood stasis, regulating QI to relieve pain.Cure mainly all pains of trusted subordinate's waist knee joint, menoxenia, WEIJIA, metrorrhagia, puerperal blood faints, lochiorrhea, traumatic injury.
Flos Lonicerae in the present invention, nature and flavor are sweet, cold.Containing Flos Lonicerae glycoside, luteolin, inositol, Saponin etc.Heat-clearing and toxic substances removing.Cure mainly the epidemic febrile disease heating, carbuncle, scabies, malignant boil, toxic swelling, toxic-heat and blood stasis, pneumonia, laryngopharynx swelling and pain, anemopyretic cold etc.
Endothelium Corneum Gigeriae Galli in the present invention, nature and flavor are sweet, flat.Containing protein, gastric hormone, biliverdin etc.Stomach invigorating, help digestion, go to amass.Cure mainly and stop dyspepsia, distension and fullness in the abdomen, regurgitation vomiting, urinary system calculus etc.
Rhizoma Cyperi in the present invention, nature and flavor suffering, micro-hardship, temperature.Enter lung, liver, spleen, stomach warp.Containing glucose, fructose, starch, volatilization wet goods.The resolving depression of regulating the flow of vital energy, the pain relieving regulating menstruation.Treating the liver discomfort in the stomach, depression of QI, breast abdomen distending pain over the hypochondrium, phlegm retention feeling of fullness, menoxenia, bleeding not during menses.
The Radix Linderae in the present invention, nature and flavor are hot, warm.Containing volatile oil, Radix Linderae terpenes, the Radix Linderae, hand over according to ester, hydroxyl Radix Linderae lactide etc.Circulation of qi promoting the chest stuffiness relieving, dispersing cold for relieving pain.Cure mainly that apoplexy QI rising in reverse order, distending pain in the chest and hypochondrium, dyspepsia do not disappear, regurgitation vomiting, coldness and pain in the epigastrium, frequent micturition, hernia.
Radix Aucklandiae (Radix Vladimiriae) in the present invention, the nature and flavor acrid, bitter, warm.Containing volatile oil, resin, glucose, saussurine.Regulating QI to relieve pain, warming middle-JIAO for easing the stomach.Cure mainly the invasion by pathogenic cold stagnation of QI, chest and abdomen swelling and pain, vomit, have loose bowels dysentery, tenesmus, colic of cold type.
Radix Et Rhizoma Rhei in the present invention, nature and flavor are bitter, cold.Containing chrysophanic acid, emodin, chrysophanol, aloe-emodin and physcione, galloyl glucose, gallic acid, resin, phlegmatic temperament, saccharide etc.Removing the relative excess is warm, removing mass is stagnant, clots absorbing blood.Cure mainly that excess-heat constipation, delirium are gone mad, food stagnation feeling of fullness, dysentery be from the beginning of, tenesmus, jaundice caused by damp-heat, amenorrhea, lump in the abdomen etc.
Rhizoma Zingiberis Recens in the present invention, nature and flavor are hot, hot.Enter spleen, stomach, kidney, the heart, lung meridian.Containing volatile oil, in oil, Main Ingredients and Appearance is zingiberol, zingiberene, camphene, Fructus Foeniculi, gingerol etc.Warming spleen and stomach for dispelling cold pain relieving, recuperating depleted YANG are promoted blood circulation, the dampness expectorant.For coldness and pain in the epigastrium, vomiting have loose bowels, cold extremities faint pulse, phlegm retention breath with cough.Growth that to a certain extent can anticancer, reduce the content of Blood Cholesterol greatly, also has some antibiotic effect, especially fairly obvious to Salmonella.And very strong choleretic effect arranged.In the present invention, Rhizoma Zingiberis is concocted as the carbonization of part epidermis, with enhancing, hold back insertion tendon blood antiulcer effect.
Radix Angelicae Sinensis in the present invention, nature and flavor are sweet, hot.Containing volatile oil, brown eleostearic acid, sucrose, vitamin B
1, nicotinic acid, vitamin E.Enriching blood blood, blood stasis dispersing and fresh blood promoting, regulating menstruation are moisturized, intestine moistening stomach, warming middle-JIAO to relieve pain.Cure mainly blood deficiency headache, pain in the lumbar region, all pains of trusted subordinate, constipation due to dry stool, flaccidity syndrome and arthralgia syndrome, WEIJIA, ulcer sores, menalgia, metrorrhagia, gastrolithiasis etc.
Radix Notoginseng in the present invention, sweet, the micro-hardship of nature and flavor, temperature.Containing multiple triterpenoid saponin (arasaponin first, the second grade).Dissipating blood stasis hemostasis, subduing swelling and relieving pain.Cure mainly the diseases such as various hemorrhage, traumatic injury an ancient egg-shaped, holed wind instrument wounds, carbuncle pain, puerperal blood faints, abdominal pain due to blood stasis.
Charred Radix Sanguisorbae in the present invention, concoct and form for the Chinese medicine Radix Sanguisorbae, and nature and flavor are bitter, cold.Containing tannin and sanguisorbin etc.Heat clearing away, removing heat from blood, hemostasis.Treatment by oral administration of medicines hemorrhoidal hamorrhage anal fistula, the external treatment burn and scald.
Radix Glycyrrhizae in the present invention, nature and flavor are sweet, flat.Enter the heart, lung, stomach, spleen channel.Containing glycyrrhizin, liquiritin, liquiritigenin, organic acid etc.Tonifying the spleen and stomach, antiulcer, heat-clearing and toxic substances removing, eliminate the phlegm, cough-relieving and middle relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, lack of appetite stomachache, constipation, overstrain heating, consumptive lung disease cough, the frightened pain of cardiopalmus, laryngopharynx swelling and pain, peptic ulcer, solution poison of drug and alimentary toxicosis.
The cause of disease of peptic ulcer mostly is Deficiency and coldness of spleen and stomach, incoordination between the liver and stomach, syndrome of liver-stomach heat and blood stasis and stagnates.The present invention has strengthening the spleen and nourishing the stomach, heat-clearing and toxic substances removing, regulating QI to relieve pain, warming spleen and stomach for dispelling cold, antacid sore, dissipating blood stasis blood, broken stagnant gas, antiulcer effect, therefore peptic ulcer is had to good therapeutical effect.
The invention has the beneficial effects as follows: through clinical practice, prove the peptic ulcer determined curative effect, take easyly, have no side effect.
The specific embodiment
1, material medicine formula and part by weight: Radix Codonopsis 5%, the Pseudobulbus Bletillae (Rhizoma Bletillae) 7%, Fructus Crataegi 5%, Fructus Amomi 6%, Os Sepiae 8%, Pericarpium Citri Reticulatae 4%, Rhizoma Corydalis 6%, Flos Lonicerae 5.5%, Endothelium Corneum Gigeriae Galli 5%, Rhizoma Cyperi 4.5%, the Radix Linderae 6%, Radix Aucklandiae (Radix Vladimiriae) 4.5%, Radix Et Rhizoma Rhei 4.5%, Rhizoma Zingiberis Recens 7%, Radix Angelicae Sinensis 6%, Radix Notoginseng 4.5%, charred Radix Sanguisorbae 4.5%, Radix Glycyrrhizae 7%.Above material medicine part by weight is absolutely.
2, by the above-mentioned raw materials medicine in proportion weight assort, with the pharmaceutical equipment apparatus concoct qualified, purify, to make the different dosage forms such as capsule, tablet, pill, granule, oral liquid after concentrated, mix homogeneously standby.
Claims (1)
1. a medicine for the treatment of peptic ulcer, it is characterized in that material medicine formula and part by weight are Radix Codonopsis 5%, the Pseudobulbus Bletillae (Rhizoma Bletillae) 7%, Fructus Crataegi 5%, Fructus Amomi 6%, Os Sepiae 8%, Pericarpium Citri Reticulatae 4%, Rhizoma Corydalis 6%, Flos Lonicerae 5.5%, Endothelium Corneum Gigeriae Galli 5%, Rhizoma Cyperi 4.5%, the Radix Linderae 6%, Radix Aucklandiae (Radix Vladimiriae) 4.5%, Radix Et Rhizoma Rhei 4.5%, Rhizoma Zingiberis Recens 7%, Radix Angelicae Sinensis 6%, Radix Notoginseng 4.5%, charred Radix Sanguisorbae 4.5%, Radix Glycyrrhizae 7%, the part by weight of above material medicine is absolutely; By the above-mentioned raw materials medicine in proportion weighing assort, with the pharmaceutical equipment apparatus concoct qualified, purify, to make the different dosage forms such as capsule, tablet, pill, granule, oral liquid after concentrated, mix homogeneously standby.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101542624A CN103417923A (en) | 2012-05-18 | 2012-05-18 | Drug for curing digestive ulcer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012101542624A CN103417923A (en) | 2012-05-18 | 2012-05-18 | Drug for curing digestive ulcer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103417923A true CN103417923A (en) | 2013-12-04 |
Family
ID=49643663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012101542624A Pending CN103417923A (en) | 2012-05-18 | 2012-05-18 | Drug for curing digestive ulcer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103417923A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104352709A (en) * | 2014-11-30 | 2015-02-18 | 侯德润 | Medicine for treating gastric ulcer and preparation method of medicine |
| CN104826060A (en) * | 2015-05-13 | 2015-08-12 | 龚灿锋 | Traditional Chinese medicine for treating ulcer of digestive system |
| CN107854632A (en) * | 2017-11-14 | 2018-03-30 | 青岛卓森纳生物工程有限公司 | A kind of slow releasing drugs of tcm for treating peptic ulcer |
-
2012
- 2012-05-18 CN CN2012101542624A patent/CN103417923A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104352709A (en) * | 2014-11-30 | 2015-02-18 | 侯德润 | Medicine for treating gastric ulcer and preparation method of medicine |
| CN104826060A (en) * | 2015-05-13 | 2015-08-12 | 龚灿锋 | Traditional Chinese medicine for treating ulcer of digestive system |
| CN107854632A (en) * | 2017-11-14 | 2018-03-30 | 青岛卓森纳生物工程有限公司 | A kind of slow releasing drugs of tcm for treating peptic ulcer |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103432532B (en) | Traditional Chinese medicine granules for treating nodules of breast and preparation method thereof | |
| CN103830749B (en) | A kind of gastrointestinal contrast agent | |
| CN102895582A (en) | Medicine treating stomach diseases | |
| CN103638475B (en) | A kind of medicinal herb spray for the treatment of nodules of the breast and preparation method thereof | |
| CN103417923A (en) | Drug for curing digestive ulcer | |
| CN101164600A (en) | Medicine for treating acne and whelk | |
| CN103550349A (en) | Oral liquid for treating postpartum anemia and preparation method | |
| CN102988946A (en) | Traditional Chinese medicine composition for treating pantalgia after childbirth | |
| CN103041328A (en) | Traditional Chinese medicine composition for treating blood stasis type lochiorrhea | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN104225054A (en) | Traditional Chinese medicine pills for treating tubal obstruction | |
| CN102579872B (en) | Medical composition with weight reducing function | |
| CN101130032A (en) | Proprietary Chinese medicine for building up body, qi-benefitting and blood-nourishing after miscarriage or dilatation curettage | |
| CN105749172A (en) | Medicament for treating gastric calculus and preparation thereof | |
| CN105362914A (en) | Traditional Chinese medicinal composition for treating chronic gastritis | |
| CN101357208A (en) | Traditional Chinese medicine composition for treating chronic superficial gastritis | |
| CN104173973A (en) | Oral liquid for treating dysentery and preparation method of oral liquid | |
| CN104257986A (en) | Traditional Chinese medicine for treating nephritis | |
| CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
| CN103751622B (en) | A kind of pharmaceutical composition for the treatment of coronary heart disease | |
| CN105412765A (en) | Traditional Chinese medicine for treating kidney-yang deficiency infertility | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof | |
| CN104147548A (en) | Preparation method of traditional Chinese medicine treating nodules of breast | |
| CN104173939A (en) | Traditional Chinese medicine for treating breast nodules and preparation method thereof | |
| CN104784401A (en) | Traditional Chinese medicine preparation for treating stomach cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20131204 |